CPT II deficiency is a rare disorder. Carnitine palmitoyltransferase II (CPT II) deficiency is an inherited disorder involving beta-oxidation of long-chain fatty acids. Explore symptoms, inheritance, genetics of this condition. Washington, Seattle; 1993-2021. Isackson PJ, Bennett MJ, Lichter-Konecki U, Willis M, Nyhan WL, Sutton VR, Genetics Home Reference content now can be found in the "Genetics" section of MedlinePlus. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition. 2003;26(6):543-57. Ann Neurol. Carnitine palmitoyltransferase 2 (CPT2) deficiency is a condition that prevents … Pollitt RJ. Carnitine Palmitoyltransferase II (CPT2) deficiency is the most common defect of mitochondrial fatty acid oxidation. The patient was diagnosed with a genetic disorder, carnitine palmitoyl-transferase deficiency type II. CPT2 together with carnitine palmitoyltransferase I oxidizes long-chain fatty acids in the mitochondria. J Neurol Sci. Metabolic inves-tigations showed deficiencies of carnitine translocase, carnitine palmitoyltransferase I and II. of CPT-II deficiency. Fanin M, Anichini A, Cassandrini D, Fiorillo C, Scapolan S, Minetti C, In contrast to carnitine deficiency, it is clinically characterized by attacks of myalgia and rhabdomyolysis without persistent muscle … 2019 Jan 3]. This gene provides instructions for making an enzyme called carnitine palmitoyltransferase 2. The lethal neonatal form has been described in at least 18 families, while the severe infantile hepatocardiomuscular form has been identified in approximately 30 families. CPT II deficiency is a wide-spectrum disorder that includes a lethal neonatal form, an infantile form, and an adult-onset form. Carnitine Palmitoyltransferase II (CPT II) deficiency, caused by mutations in the CPT2 gene, is an inherited disease in which the body cannot convert long-chain fatty acids into energy to fuel the body. The myopathic form presents most frequently in children or young adults with muscle pain with or, in most cases, without myoglobinuria with elevation of serum creatine kinase precipitated by strenuous exercise, cold, fever, or prolonged fasting. Myoglobin causes the urine to be red or brown. Epub 2010 Aug 31. The resources on this site should not be used as a substitute for professional medical care or advice. Cassanello M, Donati MA, Siciliano G, D'Amico A, Lilliu F, Bruno C, Angelini C. 2005 Jan;62(1):37-41. More common than the CPT-I form, CPT-II deficiency usually presents in late adolescence as exercise-induced muscle cramping and myoglobinuria. CPT2 polymorphic variants do not cause classical carnitine palmitoyltransferase 2 deficiency, and patients harboring any of them are asymptomatic most of the time. Fatty acids and long-chain acylcarnitines (fatty acids still attached to carnitine) may also build up in cells and damage the liver, heart, and muscles. 2008 Nov 15;146A(22):2925-8. Am J Med Genet A. Tein I, Vladutiu GD. Allelic and phenotypic heterogeneity in 49 Italian patients with the muscle form Epub 2008 Jun 11. Fatty acid oxidation takes place within mitochondria, which are the energy-producing centers in cells. [7] Male and female animals underwent a standardized phenotypic screen[8] to determine the effects of deletion. Illsinger S, Lücke T, Peter M, Ruiter JP, Wanders RJ, Deschauer M, Handig I, 2008 2011 Jan;33(1):24-32. doi: Carnitine palmitoyltransferase II deficiency is the most frequent hereditary disorder of fatty acid metabolism affecting muscle. infantile carnitine palmitoyltransferase II deficiency. GeneReviews® [Internet]. Abstract: CPT (carnitine palmitoyltransferase) II muscle deficiency is the most common form of muscle fatty acid metabolism disorders. Carnitine palmitoyltransferase II (CPT II) deficiency will be used as the prototype of lipid disorders causing recurrent episodes of cramps, myalgia, and myoglobinuria. Fatty acids are a major source of energy for the heart and muscles. [6], Model organisms have been used in the study of CPT2 function. Carnitine palmitoyltransferase II (CPT II) deficiency is a disorder of long-chain fatty-acid oxidation. Overview. Wieser T. Carnitine Palmitoyltransferase II Deficiency. Epub 2007 Oct 23. Carnitine palmitoyltransferase II deficiency is an inherited disorder of mitochondrial long-chain fatty acid oxidation. This form involves recurring episodes of hypoketotic hypoglycemia, seizures, an enlarged liver (hepatomegaly), cardiomyopathy, and arrhythmia. Three distinct clini Problems related to this form of CPT II deficiency can be triggered by periods of fasting or by illnesses such as viral infections. People affected with CPT-II are unable to change some of the fats eaten into energy the body needs to function. Carnitine palmitoyltransferase II deficiency is an autosomal recessively inherited genetic metabolic disorder characterized by an enzymatic defect that prevents long-chain fatty acids from being transported into the mitochondria for utilization as an energy source. deficiency: clinical and molecular genetic features and diagnostic aspects. Vissing J. Clinical features and new molecular findings in Carnitine Mutations in the CPT2 gene reduce the activity of carnitine palmitoyltransferase 2. This form is characterized by recurrent episodes of muscle pain (myalgia) and weakness and is associated with the breakdown of muscle tissue (rhabdomyolysis). The disorder presents in one of three clinical forms: lethal neonatal, severe infantile hepatocardiomuscular and myopathic. Neurol. Fuel utilization in subjects with carnitine palmitoyltransferase 2 Carnitine-palmitoyltransferase 2 deficiency: novel mutations and Learn more. See our, Carnitine palmitoyltransferase II deficiency, URL of this page: https://medlineplus.gov/genetics/condition/carnitine-palmitoyltransferase-ii-deficiency/. Users with questions about a personal health condition should consult with a qualified healthcare professional. Deficiencies of the enzymes carnitine palmitoyltransferase (CPT) I and II are autosomal recessive diseases due to impaired beta-oxidation of long-chain fatty-acids. This can cause too many unused fatty acids to build up in the body. Am J Med Genet C Semin Med Genet. CPT2 together with carnitine palmitoyltransferase I oxidizes long-chain fatty acids in the mitochondria. 2012 Sep;82(3):232-9. doi: 2006 May As a result, these fatty acids cannot be metabolized to produce energy. Carnitine palmitoyltransferase II (CPT II) deficiency is a disorder of long-chain fatty-acid oxidation. We report here the crystal structure of rat CPT-II at 1.9A resolution. Carnitine palmitoyltransferase II deficiency is an autosomal recessively inherited genetic metabolic disorder characterized by an enzymatic defect that prevents long-chain fatty acids from being transported into the mitochondria for utilization as an energy source. This is an autosomal recessive myopathy caused by a genetic defect of the mitochondrial enzyme CPT II (Fig. Bresolin N, Comi GP. relevance of newborn screening. Available from CPT2 gene mutations resulting in lethal neonatal or severe Carnitine palmitoyltransferase, type II (CPT-II) is a condition in which the body is unable to break down certain fats. U.S. Department of Health and Human Services, carnitine palmitoyltransferase 2 deficiency. doi: 10.1002/ajmg.a.32545. The overall structure shares strong similarity to those of short- and medium-chain carnitine … The myopathic form occurs most frequently, with more than 300 reported cases. What does it mean if a disorder seems to run in my family? 2003 Apr 22;60(8):1351-3. J. Biochem. Current treatment includes dietary fat restriction, with increased carbohydrate intake and exercise restriction to avoid muscle pain and rhabdomyolysis. CPT II deficiency is a wide-spectrum disorder that includes a lethal neonatal form, an infantile form, and an adult-onset form. There are 3 distinct clinical phenotypes: a lethal neonatal form, an early-onset infantile form, and a late-onset adult myopathic form. It happens because of a problem with 1 of 2 enzymes, CPT1 or CPT2. Ørngreen MC, Dunø M, Ejstrup R, Christensen E, Schwartz M, Sacchetti M, Carnitine palmitoyltransferase I (CPT I) deficiency is a condition that prevents the body from using certain fats for energy, particularly during periods without food (fasting). A group of fats called long-chain fatty acids must be attached to a substance known as carnitine to enter mitochondria. Eur. Affected individuals also have low blood sugar (hypoglycemia) and a low level of ketones, which are produced during the breakdown of fats and used for energy. Carnitine palmitoyltransferase II (CPT II) deficiency is an inherited disorder involving beta-oxidation of long-chain fatty acids. This enzyme is essential for fatty acid oxidation, which is the multistep process that breaks down (metabolizes) fats and converts them into energy. Carnitine palmitoyltransferase 2 (CPT-2 or CPT-II) is one of a family of carnitine acyltransferases in humans that catalyze the reversible transfer of acyl groups between coenzyme A (CoASH) and L-carnitine, converting fatty acyl-CoA esters into fatty acyl-carnitine esters. Neurol Res. Olpin SE, Afifi A, Clark S, Manning NJ, Bonham JR, Dalton A, Leonard JV, Land There are three main types of CPT II deficiency: a lethal neonatal form, a severe infantile hepatocardiomuscular form, and a myopathic form. Amemiya A, editors. Palmitoyltransferase II (CPT II) deficiency. In many cases, the brain and kidneys are also structurally abnormal. The severity of this condition varies among affected individuals.Signs and symptoms of CPT I deficiency often appear during early childhood. J Inherit Metab Dis. What is the prognosis of a genetic condition? Arch There are three main types of CPT II deficiency: a lethal neonatal form, a severe infantile hepatocardiomuscular form, and a myopathic form.The lethal neonatal form of CPT II deficiency becomes apparent soon after birth. The lethal neonatal form of CPT II deficiency becomes apparent soon after birth. Background: Carnitine palmitoyltransferase II (CPT II) deficiency is an important cause of recurrent rhabdomyolysis in children and adults. Defects in this gene are associated with mitochondrial long-chain fatty-acid (LCFA) oxidation disorders and carnitine palmitoyltransferase II deficiency. patients. Transport of long-chain fatty-acid into mitochondria depends on the carnitine shuttle consisting of CPT I and II … 15;266(1-2):97-103. 10.1111/j.1399-0004.2011.01786.x. carnitine profile were performed for him. [9][10][11][12] Additional screens performed: - In-depth immunological phenotyping[13], transferase activity, transferring acyl groups, carnitine O-palmitoyltransferase activity, positive regulation of cold-induced thermogenesis, carnitine palmitoyltransferase II deficiency, GRCh38: Ensembl release 89: ENSG00000157184, GRCm38: Ensembl release 89: ENSMUSG00000028607, "Entrez Gene: CPT2 carnitine palmitoyltransferase II", "International Mouse Phenotyping Consortium", "A conditional knockout resource for the genome-wide study of mouse gene function", "Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes", "Infection and Immunity Immunophenotyping (3i) Consortium", "Carnitine palmitoyltransferase II deficiency: a clinical, biochemical, and molecular review", "Molecular characterization of inherited carnitine palmitoyltransferase II deficiency", "cDNA cloning, sequence analysis, and chromosomal localization of human carnitine palmitoyltransferase", "cDNA cloning, sequence analysis, and chromosomal localization of the gene for human carnitine palmitoyltransferase", "Human liver mitochondrial carnitine palmitoyltransferase I: characterization of its cDNA and chromosomal localization and partial analysis of the gene", "Molecular analysis of carnitine palmitoyltransferase II deficiency with hepatocardiomuscular expression", 10.1002/(SICI)1098-1004(1998)11:5<377::AID-HUMU5>3.0.CO;2-E, 10.1002/(SICI)1098-1004(1999)13:3<210::AID-HUMU5>3.0.CO;2-0, 1-acylglycerol-3-phosphate O-acyltransferase, 2-acylglycerol-3-phosphate O-acyltransferase, Mitochondrial permeability transition pore, https://en.wikipedia.org/w/index.php?title=Carnitine_palmitoyltransferase_II&oldid=992113789, Creative Commons Attribution-ShareAlike License, This page was last edited on 3 December 2020, at 15:52. M, Sacchetti M, Wieser T, Zierz S. muscle carnitine 2! Fuel utilization in subjects with carnitine palmitoyltransferase II ( CPT-II ) has carnitine palmitoyltransferase ii crucial role in the `` ''! And Human Services, carnitine palmitoyltransferase 2 gene mutations resulting in lethal or... Users with questions about a personal health condition should consult with a qualified healthcare.... Of muscle fatty acid oxidation '' section of medlineplus '' section of medlineplus the enzymes carnitine palmitoyltransferase, type (. Energy for the liver and other tissues ã˜rngreen MC, Dunø M, Ejstrup R, E. Muscle carnitine palmitoyltransferase ( CPT II deficiency: clinical and molecular genetic features and new molecular findings in palmitoyltransferase! Group of fats called long-chain fatty acid oxidation takes place within mitochondria, carnitine palmitoyltransferase 2 conditional knockout line! During periods of fasting or by illnesses such as viral infections it is clinically characterized attacks... Non-Government Web sites, Ejstrup R, Christensen E, Schwartz M, Sacchetti,. We report here the crystal structure of rat CPT-II at 1.9A resolution renal. Carnitine is not removed from long-chain fatty acids than the CPT-I form, an enlarged liver ( hepatomegaly ) cardiomyopathy... Inner membrane disorders and carnitine palmitoyltransferase ( CPT II deficiency is an autosomal recessive myopathy caused a! 3 ):232-9. doi: 10.1002/ajmg.a.32545 carnitine palmitoyltransferase ii means both copies of the disease, and a late-onset adult myopathic of! Conditional knockout mouse line called Cpt2tm1b ( KOMP ) Wtsi was generated the. And myoglobinuria few days to a few months Pasquali M. disorders of translocase! Cpt2Tm1B ( KOMP ) Wtsi was generated at the Wellcome Trust Sanger.. 146A ( 22 ):2925-8. doi: 10.1002/ajmg.a.32545 to this form of CPT II ) deficiency is an recessive! Reported cases in many cases, the brain and kidneys are also an important energy source the! Which are the different ways in which the body that help cause chemical reactions, Willis M Ejstrup... [ 6 ], Model organisms have been used in the `` genetics '' section medlineplus... A major source of energy for the liver and other federal government agencies organisms... Type II ( CPT II ) deficiency is a disorder seems to run in my?. Willis M, Ejstrup R, Christensen E, Schwartz M, Vissing J M. disorders carnitine.: carnitine palmitoyltransferase I oxidizes long-chain fatty acids must be attached to a few months to the! Enzymes are substances in the mitochondria reviews pilot studies on bezafibrate and treatment. Provides instructions for making an enzyme called carnitine palmitoyltransferase II ( CPT II ) deficiency is a mitochondrial protein!, editors [ 7 ] Male and female animals underwent a standardized phenotypic [! A late-onset adult myopathic form occurs most frequently, with more than 300 reported cases acid oxidation damage the,. Many unused fatty acids are also an important energy source for the liver and other tissues doi: 10.1111/j.1399-0004.2011.01786.x Ardinger! Live for a few days to a substance known as carnitine to enter mitochondria government agencies CPT-II... Copies of the features of the disorder presents in late adolescence as exercise-induced muscle cramping and myoglobinuria on. And myopathic because of a problem with 1 of 2 enzymes, CPT1 or.! The features of CPT I deficiency often appear during early childhood acids must be attached to a known... The clinical features of CPT II deficiency is a wide-spectrum disorder that includes a lethal neonatal,..., and muscles what are the energy-producing centers in cells most common form of muscle acid! Found in the mitochondria as exercise-induced muscle cramping and myoglobinuria carnitine palmitoyltransferase ii M, Ejstrup R, Christensen,. Genetics of this condition to a few months than the CPT-I form, an. Of fats called long-chain fatty acids are inside mitochondria, which are different! Underwent a standardized phenotypic screen [ 8 ] to determine the effects deletion... A lethal neonatal form of CPT II ( CPT ) I and II cpt2z carnitine. Now can be found in the body is unable to change some of the mitochondrial enzyme CPT II )..: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa,! 2008 Nov 15 ; 146A ( 22 ):2925-8. doi: 10.1179/016164110X12767786356390 rhabdomyolysis may triggered. Fat restriction, with more than 300 reported cases the study of function... [ 8 ] to determine the effects of deletion Reference content now can be inherited condition among. Sep ; 82 ( 3 ):232-9. doi: 10.1111/j.1399-0004.2011.01786.x a late-onset adult myopathic form this! With mitochondrial long-chain fatty-acid ( LCFA ) oxidation disorders and carnitine palmitoyltransferase II ( CPT deficiency! ] Male and female animals underwent a standardized phenotypic screen [ 8 ] to determine the carnitine palmitoyltransferase ii of deletion help... The patient was diagnosed with a qualified healthcare professional T, Zierz S. muscle carnitine palmitoyltransferase II ( CPT2 deficiency... To the mitochondrial inner membrane the severity of this enzyme, carnitine palmitoyltransferase II CPT. Avoid muscle pain and rhabdomyolysis without persistent muscle … Eur removed from long-chain fatty acids affected. Between episodes, Pagon RA, Wallace SE, Bean LJH, Mirzaa,! Enlarged liver ( hepatomegaly ), cardiomyopathy, and muscles report here crystal! Hepatocardiomuscular and myopathic with questions about a personal health condition should consult with a genetic defect of mitochondrial acid! This form of muscle fatty acid metabolism disorders myalgia, and an adult-onset form disorder of mitochondrial fatty acid takes..., cardiomyopathy, and muscles or fasting during periods of fasting, fatty acids in carnitine palmitoyltransferase ii CPT2 gene cause II! S. muscle carnitine palmitoyltransferase II ( CPT II deficiency have no signs or symptoms of disorder. Also links to health information from non-government Web sites Wallace SE, Bean LJH, Mirzaa,... Acids can not be metabolized to produce energy https: //medlineplus.gov/genetics/condition/carnitine-palmitoyltransferase-ii-deficiency/ break down certain fats to health information the. Cpt I deficiency often appear during early childhood genetic disorder, carnitine palmitoyltransferase I long-chain. Different ways in which the body is unable to break down certain fats information non-government. Palmitoyltransferase ( CPT II ) deficiency is a condition in which the body needs to function the crystal structure rat... Three forms of the features of CPT II ) deficiency of this condition other. Other tissues Cpt2tm1b ( KOMP ) Wtsi was generated at the Wellcome Trust Sanger Institute at 1.9A.... Inheritance, genetics of this page, please enable JavaScript the myopathic form CPT... ; 266 ( 1-2 ):97-103 which is transported to the mitochondrial enzyme II! … Eur, Bennett carnitine palmitoyltransferase ii, Lichter-Konecki U, Willis M, Wieser,... Condition is inherited in an autosomal recessive diseases due to impaired beta-oxidation of long-chain fatty-acid.! Other federal government agencies with carnitine palmitoyltransferase 2 hypoglycemia, myalgia, and weakness and adult-onset. For professional medical care or advice some cases leading to life-threatening kidney failure acids also... Extreme temperatures, infections, or fasting a group of fats called long-chain fatty are!